DocGo Inc. (NASDAQ:DCGO – Get Free Report) has earned an average recommendation of “Moderate Buy” from the six research firms that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $4.89.
Several research firms have commented on DCGO. Deutsche Bank Aktiengesellschaft lowered shares of DocGo from a “buy” rating to a “hold” rating and lowered their price objective for the company from $5.00 to $2.85 in a research report on Friday, February 28th. Stifel Nicolaus dropped their price target on DocGo from $6.50 to $5.50 and set a “buy” rating for the company in a research report on Friday, February 28th. Finally, Needham & Company LLC decreased their price objective on DocGo from $7.00 to $4.00 and set a “buy” rating on the stock in a research report on Friday, February 28th.
Check Out Our Latest Stock Analysis on DocGo
DocGo Price Performance
Institutional Trading of DocGo
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in DCGO. Summit Investment Advisors Inc. grew its stake in shares of DocGo by 38.7% during the fourth quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company’s stock valued at $45,000 after buying an additional 2,968 shares during the last quarter. Centiva Capital LP bought a new position in DocGo in the 3rd quarter valued at $43,000. Prudential Financial Inc. purchased a new stake in DocGo in the fourth quarter worth $55,000. Royce & Associates LP bought a new stake in shares of DocGo during the fourth quarter worth $64,000. Finally, Intech Investment Management LLC bought a new stake in shares of DocGo during the third quarter worth $62,000. 56.44% of the stock is owned by hedge funds and other institutional investors.
About DocGo
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Further Reading
- Five stocks we like better than DocGo
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- What is the Euro STOXX 50 Index?
- Top 3 Beverage Stocks Pouring Out Profits
- Stock Market Sectors: What Are They and How Many Are There?
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.